IHS Chemical Week

World News and Views :: Projects

Lonza Breaks Ground on Singapore Biologics Plant

1:12 PM MDT | July 24, 2007 | Chemical Week Editorial Staff

Lonza and Bio*One Capital (Singapore) have broken ground on a previously announced project to build a large-scale commercial mammalian cell culture manufacturing facility in Singapore (CW, Dec. 13, 2006, p. 29). The plant is being built in the Tuas Biomedical Park, and will be Lonza’s second large-scale mammalian manufacturing plant in Singapore and its third worldwide. It will have up to four mammalian bioreactor trains, each with a flexible capacity of 1,000 liters-20,000 liters. Completion is scheduled by 2011. The investment could total $350 million...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa